IBDEI0NN ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10524,0)
 ;;=H40.1111^^74^682^6
 ;;^UTILITY(U,$J,358.3,10524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10524,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Right Eye
 ;;^UTILITY(U,$J,358.3,10524,1,4,0)
 ;;=4^H40.1111
 ;;^UTILITY(U,$J,358.3,10524,2)
 ;;=^5138537
 ;;^UTILITY(U,$J,358.3,10525,0)
 ;;=H40.1121^^74^682^7
 ;;^UTILITY(U,$J,358.3,10525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10525,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Left Eye
 ;;^UTILITY(U,$J,358.3,10525,1,4,0)
 ;;=4^H40.1121
 ;;^UTILITY(U,$J,358.3,10525,2)
 ;;=^5138542
 ;;^UTILITY(U,$J,358.3,10526,0)
 ;;=H40.013^^74^682^4
 ;;^UTILITY(U,$J,358.3,10526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10526,1,3,0)
 ;;=3^Glaucoma Suspect,Low Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,10526,1,4,0)
 ;;=4^H40.013
 ;;^UTILITY(U,$J,358.3,10526,2)
 ;;=^5005726
 ;;^UTILITY(U,$J,358.3,10527,0)
 ;;=H40.023^^74^682^5
 ;;^UTILITY(U,$J,358.3,10527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10527,1,3,0)
 ;;=3^Glaucoma Suspect,High Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,10527,1,4,0)
 ;;=4^H40.023
 ;;^UTILITY(U,$J,358.3,10527,2)
 ;;=^5005730
 ;;^UTILITY(U,$J,358.3,10528,0)
 ;;=H40.1132^^74^682^11
 ;;^UTILITY(U,$J,358.3,10528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10528,1,3,0)
 ;;=3^Primary Open-Angle Gluacoma,Mod Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,10528,1,4,0)
 ;;=4^H40.1132
 ;;^UTILITY(U,$J,358.3,10528,2)
 ;;=^5138548
 ;;^UTILITY(U,$J,358.3,10529,0)
 ;;=H40.1232^^74^682^19
 ;;^UTILITY(U,$J,358.3,10529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10529,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mod,Bilateral
 ;;^UTILITY(U,$J,358.3,10529,1,4,0)
 ;;=4^H40.1232
 ;;^UTILITY(U,$J,358.3,10529,2)
 ;;=^5005769
 ;;^UTILITY(U,$J,358.3,10530,0)
 ;;=H40.1113^^74^682^12
 ;;^UTILITY(U,$J,358.3,10530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10530,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Sev Stage,Right Eye
 ;;^UTILITY(U,$J,358.3,10530,1,4,0)
 ;;=4^H40.1113
 ;;^UTILITY(U,$J,358.3,10530,2)
 ;;=^5138539
 ;;^UTILITY(U,$J,358.3,10531,0)
 ;;=H40.1123^^74^682^13
 ;;^UTILITY(U,$J,358.3,10531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10531,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Sev Stage,Left Eye
 ;;^UTILITY(U,$J,358.3,10531,1,4,0)
 ;;=4^H40.1123
 ;;^UTILITY(U,$J,358.3,10531,2)
 ;;=^5138544
 ;;^UTILITY(U,$J,358.3,10532,0)
 ;;=H40.022^^74^682^24
 ;;^UTILITY(U,$J,358.3,10532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10532,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,High Risk,Left Eye
 ;;^UTILITY(U,$J,358.3,10532,1,4,0)
 ;;=4^H40.022
 ;;^UTILITY(U,$J,358.3,10532,2)
 ;;=^5005729
 ;;^UTILITY(U,$J,358.3,10533,0)
 ;;=H40.021^^74^682^23
 ;;^UTILITY(U,$J,358.3,10533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10533,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,High Risk,Right Eye
 ;;^UTILITY(U,$J,358.3,10533,1,4,0)
 ;;=4^H40.021
 ;;^UTILITY(U,$J,358.3,10533,2)
 ;;=^5005728
 ;;^UTILITY(U,$J,358.3,10534,0)
 ;;=H40.1131^^74^682^8
 ;;^UTILITY(U,$J,358.3,10534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10534,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,10534,1,4,0)
 ;;=4^H40.1131
 ;;^UTILITY(U,$J,358.3,10534,2)
 ;;=^5138547
 ;;^UTILITY(U,$J,358.3,10535,0)
 ;;=H40.1112^^74^682^9
 ;;^UTILITY(U,$J,358.3,10535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10535,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mod Stage,Right Eye
